Clinical trial
Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
NCT00050713 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00050713 |
|---|---|
| Title | Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy |
| Official title | Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Membranous Glomerulonephritis, Lupus Membranous Nepropathy |
| Intervention type | Drug |
| Interventions | Sirolimus |
| Enrollment | 12 |
| Start date | Dec 17, 2002 |
| Primary completion | Aug 27, 2007 |
| Completion | Aug 27, 2007 |
| First posted | Dec 18, 2002 |
| Last update posted | Oct 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: